Advertisement
07/15/2021

Aurobindo obtains FDA OK for generic Lioresal

Baclofen tablets have a market value of roughly $77 million for the 12 months ended May 2021, according to IQVIA.
Sandra Levy
Senior Editor
Sandra Levy profile picture
Image
diagram

The Food and Drug Administration has greenlighted Aurobindo’s baclofen tablets in dosage strengths of 10 mg and 20 mg.

The product is the generic of Novartis’ Lioresal.

Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal chord diseases.

Baclofen tablets have a market value of roughly $77 million for the 12 months ended May 2021, according to IQVIA.

    Advertisement
    Advertisement